Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Warns Oversized, Unmarked Droppers Could Lead To Vitamin D Overdose

This article was originally published in The Tan Sheet

Executive Summary

FDA recommends firms limit the size of droppers accompanying liquid vitamin D supplements for infants to the maximum recommended daily amount to reduce the risk of overdose

You may also be interested in...

FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance

Some drug firms may need to alter their product packaging and labeling to comply with FDA's guidance on dosing device labeling for liquid OTCs

FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input

FDA expects to accomplish the goals of its Safe Use Initiative through a combination of voluntary moves by industry and regulatory activities

Pediatricians Double Recommended Vitamin D Intake, Suggest Earlier Use

The American Academy of Pediatrics doubles its recommendation for daily vitamin D intake by infants, children and adolescents to 400 IU and advises earlier supplementation with the vitamin


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts